The Ghana Health Service (GHS) is confronting a mounting legal and fiscal crisis, with medical-legal claims against its facilities ballooning to an estimated GH¢400 million over the past three years, a senior official has disclosed.
The staggering figure stems from 173 formal cases recorded between 2023 and 2025, illustrating a sharp and worrying upward trajectory in litigation against public health institutions. According to data presented by Dr Caroline Reindorf Amissah, Deputy Director-General of the GHS, the number of lawsuits has more than doubled within the period, surging from 40 in 2023 to 44 in 2024, and spiking dramatically to 89 in 2025 alone.
Speaking at the opening of a five-day structured legal training programme for GHS legal officers in Accra, Dr Amissah warned that the trend poses “significant financial and reputational risks” to the nation’s healthcare delivery system. The claims encompass allegations of medical negligence, wrong or delayed diagnosis, treatment and medication errors, inadequate informed consent, and injury or death allegedly resulting from substandard care.
The GH¢400 million figure is particularly alarming in a country where the Ministry of Health’s annual capital budget is heavily constrained. If sustained or allowed to escalate, this fiscal burden could divert critical resources away from essential medical supplies, infrastructure upgrades, and staff remuneration—potentially crippling service delivery at the very facilities meant to save lives.
Dr Amissah, who oversees clinical operations at the GHS, stressed that recurring disputes are not merely financial but are also eroding public confidence. She noted that some referral hospitals are increasingly being stigmatised by sections of the public as “death traps”—a perception she attributes to the high volume of critically ill patients referred to these institutions from lower-level health centres, rather than intrinsic negligence.
“Deaths or poor outcomes at such facilities do not necessarily indicate negligence,” Dr Amissah clarified, pointing out that many patients only present at tertiary hospitals after their conditions have significantly deteriorated, often rendering interventions futile.
The five-day legal training programme, currently underway in Accra, is designed to bolster the GHS’s internal capacity to manage these complex claims. The curriculum focuses on evidence gathering, strict documentation standards, and the use of Alternative Dispute Resolution (ADR) to mitigate prolonged court battles, which often inflate payout costs due to legal fees and accrued interest.
Dr Amissah used the platform to issue a strong directive to healthcare workers to uphold patients’ rights, particularly regarding informed consent. She emphasised that proposed treatments, procedures, and inherent risks must be communicated clearly to patients and their families. In cases where patients decline treatment despite being adequately counselled, she insisted that such decisions must be meticulously documented to shield both the provider and the patient from future misunderstandings.
Crucially, Dr Amissah redefined the GHS’s strategic objective, stating that the goal “should not simply be to reduce the number of lawsuits” but to identify and address the preventable systemic failures that lead to legitimate claims. This calls for a robust shift towards regular clinical audits, continuous medical education, and stringent quality assurance mechanisms across all health facilities.
The surge in claims also raises broader questions about the adequacy of Ghana’s medical indemnity insurance framework and the efficiency of the judicial process in handling medical torts. Legal experts note that while the Ghana Patients’ Charter guarantees the right to information and consent, many patients remain unaware of proper redress channels, resulting in a mix of rightful claims and opportunistic litigation that clogs the courts.
As the GHS grapples with this growing liability, Dr Amissah renewed her call for intensified public education campaigns. She urged Ghanaians to seek early medical care to prevent complications, improve treatment outcomes, and reduce the incidence of tragic outcomes that fuel litigation.
With 2026 already underway, health sector stakeholders are watching closely to see whether the ongoing training initiatives and heightened awareness among clinicians will stem the tide of claims—or if the GHS is headed for an even costlier legal storm.
